GuideInfectious diseases
COVID-19: triage, diagnosis and treatment (current status)
Summarises severity classification, diagnosis and the treatments recommended today by WHO, including those no longer used.
Updated 3 November 2026
When to use it
Patient with confirmed or suspected COVID-19, to classify severity and choose treatment according to current living guidelines.
Warning
Replaces 2020–2021 resources (Medscape resource centre, NEJM interview on monoclonals and boosters, triage guide) that are now outdated. Based on WHO living guidelines on clinical management (June 2025) and therapeutics, and its vaccine position paper (July 2026); always check the current version.
Severity classification (WHO)
• Non-severe: no severity criteria.
• Severe: SpO2 < 90% on room air, signs of severe pneumonia or severe respiratory distress (accessory muscle use, unable to complete sentences, respiratory rate > 30/min in adults).
• Critical: ARDS, sepsis, septic shock or need for life-sustaining therapy (invasive or non-invasive ventilation, vasopressors).
Risk of progression is also judged by age, comorbidity, immunosuppression and vaccination status.
Keep reading in the app
- Diagnosis
- Recommended treatment
- What is no longer recommended
- Current sources
Practical tip
Severity is decided at the bedside: SpO2 < 90% on room air or severe respiratory distress already means severe COVID-19.
3 more practical tips in the app.
Reference
- World Health Organization. Clinical management of COVID-19: living guideline, June 2025. Geneva: WHO; 2025.
- World Health Organization. Therapeutics and COVID-19: living guideline. Geneva: WHO; 2025.
- Agarwal A, Hunt B, Stegemann M, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020;370:m3379 (living updates).
- Infectious Diseases Society of America. IDSA Guidelines on the Treatment and Management of Patients with COVID-19 (living guideline).
- World Health Organization. COVID-19 vaccines: WHO position paper – July 2026. Wkly Epidemiol Rec. 2026;101(30).
Official source: WHO: Therapeutics and COVID-19 living guideline
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
